Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02253420
Title COPANLISIB (BAY80-6946) Drug-drug Interaction Study in Advanced Solid Tumor Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Dallas Texas 75230 United States Details
Edmonton Alberta T6G 1Z2 Canada Details
Vancouver British Columbia V5Z 4E6 Canada Details
Hamilton Ontario L8V 5C2 Canada Details
Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field